TERM ID="NYU_TERM_1" STRING="CD8" FREQUENCY=1 START=15 END=18 LEMMA="CD8" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_2" STRING="T cells" FREQUENCY=1 START=20 END=27 LEMMA="T CELL" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_3" STRING="T-cell memory lineage commitment" FREQUENCY=1 START=801 END=833 LEMMA="T-CELL MEMORY LINEAGE COMMITMENT" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_4" STRING="Tumor" FREQUENCY=1 START=0 END=5 LEMMA="TUMOR" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_5" STRING="ability" FREQUENCY=1 START=360 END=367 LEMMA="ABILITY" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_6" STRING="antitumor immune responses" FREQUENCY=1 START=377 END=403 LEMMA="ANTITUMOR IMMUNE RESPONSE" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_7" STRING="cancer cells" FREQUENCY=1 START=416 END=428 LEMMA="CANCER CELL" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_8" STRING="cancer death" FREQUENCY=1 START=123 END=135 LEMMA="CANCER DEATH" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_9" STRING="conventional treatments" FREQUENCY=1 START=222 END=245 LEMMA="CONVENTIONAL TREATMENT" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_10" STRING="cytolytic T cell response" FREQUENCY=1 START=710 END=735 LEMMA="CYTOLYTIC T CELL RESPONSE" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_11" STRING="immunotherapeutic attempts" FREQUENCY=1 START=871 END=897 LEMMA="IMMUNOTHERAPEUTIC ATTEMPT" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_12" STRING="immunotherapy" FREQUENCY=2 START=315 END=328 LEMMA="IMMUNOTHERAPY" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_13" STRING="immunotherapy" FREQUENCY=2 START=663 END=676 LEMMA="IMMUNOTHERAPY" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_14" STRING="improvements" FREQUENCY=1 START=206 END=218 LEMMA="IMPROVEMENT" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_15" STRING="positive impact" FREQUENCY=1 START=523 END=538 LEMMA="POSITIVE IMPACT" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_16" STRING="therapeutic strategies" FREQUENCY=1 START=567 END=589 LEMMA="THERAPEUTIC STRATEGY" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_17" STRING="tumor biology" FREQUENCY=1 START=461 END=474 LEMMA="TUMOR BIOLOGY" LEMMA_FREQUENCY=1
